Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  Demark Wahnefried, Wendy ^a   Nix, Jeffery W ^b   Hunter, Gary R ^a   Rais Bahrami, Soroush ^b   Desmond, Renee A ^c   Chacko, Balu ^d   Morrow, Casey D ^a   Azrad, Maria ^a   Frugé, Andrew D ^a   Tsuruta, Yuko ^a   Ptacek, Travis ^e   Tully, Scott A ^f   Segal, Roanne ^g   Grizzle, William E ^d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c and Clinical Center   (United States)

^d University of Alabama at Birmingham   (United States)

^e University of Alabama at Birmingham   (United States)

^f Urology Centers of Alabama   (United States)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Diet; Exercise; Intervention; Obesity; Physical activity; Presurgical; Prostatic neoplasms; Weight loss

Indexed keywords

ANDROGEN RECEPTOR; BIOLOGICAL MARKER; CASPASE 3; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; INSULIN; INSULIN RECEPTOR; KI 67 ANTIGEN; LEPTIN; LYMPHOTOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROSTATE SPECIFIC ANTIGEN; PROTEIN KINASE B; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; VASCULOTROPIN; TUMOR MARKER;

ADULT; AFRICAN AMERICAN; ARTICLE; BIOENERGY; BODY COMPOSITION; BODY FAT; BODY MASS; CALORIC INTAKE; CALORIC RESTRICTION; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CARDIORESPIRATORY FITNESS; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; HOSPITAL ADMISSION; HUMAN; MALE; OBESITY; PHYSICAL ACTIVITY; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TUMOR GROWTH; WAIST CIRCUMFERENCE; WEIGHT GAIN; WEIGHT REDUCTION; BLOOD; DIET; MIDDLE AGED; MOTOR ACTIVITY; PATHOLOGY; PHYSIOLOGY; PROSTATIC NEOPLASMS; TUMOR EMBOLISM;

ADULT; BIOMARKERS, TUMOR; CALORIC RESTRICTION; DIET; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEOPLASTIC CELLS, CIRCULATING; OBESITY; PROSTATECTOMY; PROSTATIC NEOPLASMS; WEIGHT LOSS;

EID: 84957056947     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2075-x     Document Type: Article

References (53)

1. Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, et al. American society of clinical oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568-74.
2. Zhao ZG, Guo XG, Ba CX, Woang W, Yang YY, Wang J, et al. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Intl Med Res. 2012;40(6):2041-50.
3. Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer. 2007;96(9):1457-61.
4. Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev. 2012;21(8):1244-59.
5. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New Engl J Med. 2003;348(17):1625-38.
6. Magheli A, Rais-Bahrami S, Trock BJ, Humphreys EB, Partin AW, Han M, et al. Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching. Urol. 2008;72(6):1246-51.
7. Yuan C, Cao Y, Chavarro J, Lindstrom S, Qiu W, Willett W, et al. Prediagnostic body-mass index, smoking and prostate cancer survival: a cohort consortium study of over 10,000 white men with prostate cancer. Cancer Epidemiol Biomarkers Prev. 2015;24(4):759-60.
8. Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res. 2011;4(4):486-501.
9. Reeves MM, Terranova CO, Eakin EG, Demark-Wahnefried W. Weight loss intervention trials in women with breast cancer: a systematic review. Obesity Rev. 2014;15(9):749-68.
10. Befort CA, Klemp JR, Austin HL, Perri MG, Schmitz KH, Sullivan DK, et al. Outcomes of a weight loss intervention among rural breast cancer survivors. Breast Cancer Res Treat. 2012;132(2):631-9.
11. Thomson CA, Stopeck AT, Bea JW, Cussler E, Nardi E, Frey G, et al. Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets. Nutr Cancer. 2010;62(8):1142-52.
12. Campbell KL, Van Patten CL, Neil SE, Kirkham AA, Gotay CC, Gelmon KA, et al. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity. J Acad Nutr Diet. 2012;112(4):559-67.
13. Greenlee HA, Crew KD, Mata JM, McKinley PS, Rundle AG, Zhang W, et al. A pilot randomized controlled trial of a commercial diet and exercise weight loss program in minority breast cancer survivors. Obes. 2013;21(1):65-76.
14. Jen KL, Djuric Z, DiLaura NM, Buison A, Redd JN, Maranci V, et al. Improvement of metabolism among obese breast cancer survivors in differing weight loss regimens. Obesity Res. 2004;12(2):306-12.
15. Scott E, Daley AJ, Doll H, Woodroofe N, Coleman RE, Mutrie N, et al. Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breast cancer: a randomized controlled trial. Cancer Causes Contr. 2013;24(1):181-91.
16. Rack B, Andergassen U, Neugebauer J, Salmen J, Hepp P, Sommer H, et al. The German SUCCESS C study - the first European lifestyle study on breast cancer. Breast Care. 2010;5(6):395-400.
17. Villarini A, Pasanisi P, Traina A, Mano MP, Bonanni B, Panico S, et al. Lifestyle and breast cancer recurrences: the DIANA-5 trial. Tumori. 2012;98(1):1-18.
18. Morey MC, Snyder DC, Sloane R, Cohen HJ, Peterson B, Hartman TJ, et al. Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA. 2009;301(18):1883-91.
19. Schenk JM, Neuhouser ML, Lin DW, Kristal AR. A dietary intervention to elicit rapid and complex dietary changes for studies investigating the effects of diet on tissues collected during invasive surgical procedures. J Am Diet Assn. 2009;109(3):459-63.
20. Wright JL, Plymate S, D'Oria-Cameron A, Bain C, Haugk K, Xiao L, et al. A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a randomized controlled trial. Prostate. 2013;73(12):1345-51.
21. Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF, Ruffin MT, et al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3577-87.
22. DeCensi A, Puntoni M, Gandini S, Guerrieri-Gonzaga A, Johansson HA, Cazzaniga M, et al. Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial. Breast Cancer Res Treat. 2014;148(1):81-90.
23. Gandini S, Guerrieri-Gonzaga A, Pruneri G, Serrano D, Cazzaniga M, Lazzeroni M, et al. Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials. Ann Oncol. 2014;25(3):618-23.
24. Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res. 1994;54(7 Suppl):2015s-24.
25. Arnaout A, Robertson S, Kuchuk I, Simos D, Pond GR, Addison CL, et al. Evaluating the feasibility of performing window of opportunity trials in breast cancer. Int J Surg Oncol. 2015;2015:785793.
26. Dinney CP, Hansel D, McConkey D, Shipley W, Hagan M, Dreicer R, et al. Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum. Urol Oncol. 2014;32(8):1108-15.
27. Dowsett M, Smith I, Robertson J, Robison L, Pinhel I, Johnson L, et al. Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer. J Natl Cancer Inst Monogr. 2011;2011(43):120-3.
28. Montironi R, Bartels PH, DeCensi A, Puntoni M, Hurle R, Decobelli O, et al. A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry. Urol Oncol. 2013;31(5):557-65.
29. Demark-Wahnefried W, George SL, Switzer BR, Snyder DC, Madden JF, Polascik TJ, et al. Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer. Clin Trials. 2008;5(3):262-72.
30. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Science Sports Exerc. 2010;42(7):1409-26.
31. Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol. 2009;27(3):344-51.
32. Jayachandran J, Banez LL, Aronson WJ, Terris MK, Presti Jr JC, Amling CL, et al. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer. 2009;115(22):5263-71.
33. Hadziabdic MO, Mucalo I, Hrabac P, Matic T, Rahelic D, Bozikov V. Factors predictive of drop-out and weight loss success in weight management of obese patients. J Hum Nutr Diet. 2015;28 Suppl 2:24-32.
34. World Cancer Research Fund/American Institute of Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, second expert report. [ http://www.dietandcancerreport.org/expert_report/ ]. Accessed 3 Feb 2016.
35. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):243-74.
36. Frankenfield DC, Rowe WA, Smith JS, Cooney RN. Validation of several established equations for resting metabolic rate in obese and nonobese people. J Am Diet Assn. 2003;103(9):1152-9.
37. Choose Your Foods Exchange List Diet. [ http://glycemic.com/DiabeticExchange/The%20Diabetic%20Exchange%20List.pdf ]. Accessed 3 Feb 2016.
38. Steinberg DM, Bennett GG, Askew S, Tate DF. Weighing every day matters: daily weighing improves weight loss and adoption of weight control behaviors. J Acad Nutr Diet. 2015;115(4):511-8.
39. Bandura A. Health promotion by social cognitive means. Health Ed Behav. 2004;31(2):143-64.
40. Kohl HW, Gibbons LW, Gordon NF, Blair SN. An empirical evaluation of the ACSM guidelines for exercise testing. Med Science Sports Exerc. 1990;22(4):533-9.
41. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign: Human Kinetics Books; 1988.
42. Fillenbaum G. Multidimensional Functional Assessment of Older Adults. Hillsdale: Lawrence Erlbaum Associates; 1988.
43. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993;2(3):217-27.
44. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36(7):1002-12.
45. Blair SN, Haskell WL, Ho P, Paffenbarger Jr RS, Vranizan KM, Farquhar JW, et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol. 1985;122(5):794-804.
46. De Keyzer W, Huybrechts I, De Vriendt V, Vandevijvere S, Slimani N, Van Oyen H, et al. Repeated 24-h recalls versus dietary records for estimating nutrient intakes in a national food consumption survey. Food Nutr Res 2011;55. doi: 10.3402/fnr.v55i0.7307
47. Subar AF, Kirkpatrick SI, Mittl B, Zimmerman TP, Thompson FE, Bingley C, et al. The Automated Self-Administered 24-h Dietary Recall (ASA24): A Resource for Researchers, Clinicians and Educators from the National Cancer Institute. J Acad Nutr Diet. 2012;112(8):1134-7.
48. Chacko BK, Kramer PA, Ravi S, Johnson MS, Hardy RW, Ballinger SW, et al. Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Lab Invest. 2013;93(6):690-700.
49. Kramer PA, Chacko BK, Ravi S, Johnson MS, Mitchell T, Darley-Usmar VM. Bioenergetics and the oxidative burst: protocols for the isolation and evaluation of human leukocytes and platelets. J Vis Exp 2014(85). doi: 10.3791/51301
50. Kumar R, Eipers P, Little RB, Crowley M, Crossman DK, Lefkowitz EJ, et al. Getting started with microbiome analysis: sample acquisition to bioinformatics. Curr Protoc Hum Genet. 2014;82:11-8. 18, 29.
51. Daft JG, Ptacek T, Kumar R, Morrow C, Lorenz RG. Cross-fostering immediately after birth induces a permanent microbiota shift that is shaped by the nursing mother. Microbiome. 2015;3:17.
52. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4516-22.
53. Adams RN, Mosher CE, Blair CK, Snyder DC, Sloane R, Demark-Wahnefried W. Cancer survivors' uptake and adherence in diet and exercise intervention trials: An integrative data analysis. Cancer. 2014;121(1):77-83.